Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Tumor-Targeted Drug Conjugate(TwoStep) in Ovarian Cancer: NCT07814248 Clinical Landscape Report 2026
11 September 2026
NCT07814248 clinical landscape for Ovarian Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
CS1-targeted autologous CAR-T cells (Hematology Hospital of Chinese Academy of Medical Sciences) in Relapse multiple myeloma: NCT07809594 Clinical Landscape Report 2026
11 September 2026
NCT07809594 clinical landscape for Relapse multiple myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
TUB-040 in Metastatic Non-Squamous Non-Small Cell Lung Carcinoma: NCT07806773 Clinical Landscape Report 2026
11 September 2026
NCT07806773 clinical landscape for Metastatic Non-Squamous Non-Small Cell Lung Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and d…
9 min read
C-CAR168 in Neuromyelitis Optica: NCT07676266 Clinical Landscape Report 2026
11 September 2026
NCT07676266 clinical landscape for Neuromyelitis Optica: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Efimosfermin alfa in Metabolic Dysfunction Associated Steatohepatitis: NCT07704892 Clinical Landscape Report 2026
11 September 2026
NCT07704892 clinical landscape for Metabolic Dysfunction Associated Steatohepatitis: endpoints, sponsor, phase, geography, readouts, asset context and develo…
9 min read
Navlimetostat in Mesothelioma, Malignant: NCT07602946 Clinical Landscape Report 2026
11 September 2026
NCT07602946 clinical landscape for Mesothelioma, Malignant: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Crizotinib in Uveal Melanoma: NCT07804186 Clinical Landscape Report 2026
11 September 2026
NCT07804186 clinical landscape for Uveal Melanoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Rentosertib in Idiopathic Pulmonary Fibrosis: NCT07687459 Clinical Landscape Report 2026
11 September 2026
NCT07687459 clinical landscape for Idiopathic Pulmonary Fibrosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Foscenvivint in Hemophilia: NCT07681089 Clinical Landscape Report 2026
11 September 2026
NCT07681089 clinical landscape for Hemophilia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Anlotinib Dihydrochloride in Unresectable Hepatocellular Carcinoma: NCT07806292 Clinical Landscape Report 2026
11 September 2026
NCT07806292 clinical landscape for Unresectable Hepatocellular Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white…
9 min read
Elagolix Sodium in Endometrial Carcinoma: NCT07763847 Clinical Landscape Report 2026
11 September 2026
NCT07763847 clinical landscape for Endometrial Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Dexamethasone Sodium Phosphate in Parotid Neoplasms: NCT07812259 Clinical Landscape Report 2026
11 September 2026
NCT07812259 clinical landscape for Parotid Neoplasms: endpoints, sponsor, phase, geography, readouts, asset context and development white space.